spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Standardized Syringe Testing with Zwick

ZwickRoell


In today's world, the medical industry is continually faced with the challenge of providing patients with better care. Glass syringes that deliver drugs to patients are an essential part of this care. These glass syringes are typically used in connection with injection needles, needless Luer locks, adapters, and transfer devices.

The need for accurate and repeatable tests on syringes is playing an increasingly important role. Standard ISO 11040-4 provides producers of syringes and drugs a shared basis for producing reliable test results.

Zwick testing solutions to ISO 11040-4

ISO 11040-4 (Prefilled syringes -- Part 4: Glass barrels for injectables and sterilized subassembled syringes ready for filling) defines the following tests:

■C1: Flange breaking resistance
■C2: Luer cone breaking resistance
■E: Glide force test method to evaluate syringe lubrication
■F: Needle penetration test
■G1: Needle pull-out force
■G2: Closure system liquid leakage test
■G3: Luer lock adaptor collar pull-off force
■G4: Luer lock adaptor collar torque resistance
■G5: Luer lock rigid tip cap unscrewing torque
■G6: Pull-off force of the tip cap or the needle shield

Zwick is the first materials testing machine manufacturer that offers a complete portfolio that tests to ISO 11040-4. The interchangeable test fixtures are ideal for various syringe types and ensure that the testing of prefilled syringes is standardized.
phone +49 7305 100
email info@zwick.com
web www.zwick.com/medical
email August-Nagel-Strasse 11, 89079, ULM, Germany
 
Print this page
Send to a friend
   
spacer
News and Press Releases

PCI Pharma Services Announces Appointment of Angi Calkins as Chief Human Resources Officer

Philadelphia, PA January 28, 2019. Leading biopharmaceutical services provider PCI Pharma Services (PCI) is pleased to announce the appointment of Angi Calkins as Senior Vice President and Chief Human Resources Officer. Angi joins PCI as the company experiences considerable growth and global expansion, currently with more than 3,500 associates, spanning eight locations comprised of 20 facilities across three continents. PCI features a broad portfolio of outsourced development and commercialization services focused in drug development and manufacturing, clinical trial supply, as well as commercial contract packaging.
More info >>


White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement